可溶性CD163在急性冠脉综合征患者血清中的表达及意义

李青; 刘昕; 林琳; 闫蕊; 魏瑾

您当前的位置：

首页 >

文章列表页 >

可溶性CD163在急性冠脉综合征患者血清中的表达及意义

临床医学 | 更新时间：2026-01-09

- 可溶性CD163在急性冠脉综合征患者血清中的表达及意义
- Clinical significance of soluble CD163 in acute coronary syndrome patients
- 陆军军医大学学报 2016年38卷第14期页码：1654-1658
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R341;R446.112;R541.404
- 纸质出版：2016
- 稿件说明：
移动端阅览
李青,刘昕,林琳,闫蕊,魏瑾.可溶性CD163在急性冠脉综合征患者血清中的表达及意义[J].陆军军医大学学报(原第三军医大学学报),2016,38(14):1654-1658.

　Li Qing,Liu Xin,Lin Lin,Yan Rui,Wei Jin.Clinical significance of soluble CD163 in acute coronary syndrome patients[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(14):1654-1658.
李青,刘昕,林琳,闫蕊,魏瑾.可溶性CD163在急性冠脉综合征患者血清中的表达及意义[J].陆军军医大学学报(原第三军医大学学报),2016,38(14):1654-1658. DOI：

　Li Qing,Liu Xin,Lin Lin,Yan Rui,Wei Jin.Clinical significance of soluble CD163 in acute coronary syndrome patients[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(14):1654-1658. DOI：

摘要

目的探讨可溶性CD163（soluble CD163，sCD163）在急性冠脉综合征患者血清中的水平及临床意义。方法以2013年2月至2014年12月在本院就诊的672例急性冠脉综合征患者和305例同期接受体检的健康成年人作为研究对象，采用酶联免疫吸附法检测两组研究对象血清中sCD163的水平，并进行相关统计学分析。结果急性冠脉综合征患者血清中sCD163水平在入院后24 h内、72 h 及30 d后均显著高于健康对照组（P0.05），急性冠脉综合征患者血清中sCD163的水平与患者的Gensini评分存在显著相关性，Gensini评分越高的患者血清中sCD163的水平越高（P0.05）；ROC曲线分析表明：以651.5 ng/mL为界值，sCD163诊断急性冠脉综合征的灵敏度为85.40%，特异度为91.52%，ROC曲线下面积为0.931 3。结论 sCD163在急性冠脉综合征患者血清中的水平明显增高，有可能成为诊断急性冠脉综合征的新指标。

Abstract

Objective To investigate the expression of serum soluble CD163 (sCD163) in the patients with acute coronary syndrome (ACS) and its clinical significance. Methods A total of 672 patients with ACS admitted to the hospital from February 2013 to December 2014 were enrolled

and 305 healthy volunteers were taken as controls. Blood samples were obtained in 24 h

72 h

and 30 d after ACS. ELISA was used to determine the expression of sCD163. The correlation between sCD163 level and Gensini score was evaluated. Results The patients with ACS showed higher expression of sCD163 than the controls in 24 h

72 h and 30 d after ACS (P0.05). Furthermore

serum sCD163 level was positively related with the Gensini score (P0.05). Based on the ROC curve

the boundary value of sCD163 was 651.5 ng/mL. The sensitivity and specificity of sCD163 in diagnosis of ACS were 85.40% and 91.52%

respectively. The area under the ROC curve was 0.931 3. Conclusion Increased serum sCD163 level may be an early predictor of outcome in patients with ACS.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

术前D-二聚体联合检测活化部分凝血活酶时间对急性冠脉综合征急诊PCI术中慢/无复流现象的预测价值

小分子血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂用于急性冠脉综合征的经皮介入治疗Meta分析

急性冠脉综合征患者血清APN、HO-1水平与冠状动脉病变严重程度的相关性研究

石杉碱甲人工抗原的合成、鉴定及免疫原性分析

Endoglin结合肽功能性亲和常数的测定